Sun On Progressing Antibe’s Non-Opioid Analgesic, Challenges In Japan

Sun Scion Elevated As COO

 
• By Anju Ghangurde
  
Progress asset
Sun to steer Antibe's novel NSAID (Shutterstock)

More from Earnings

More from R&D